Table 3.
Agent | CYP | Effect | Proposed Mechanism | Reference |
---|---|---|---|---|
Diet in Vivo | ||||
SPI | CYP4A14 | Increased Hepatic Expression | PPARα Activation | Badger et al. (2008) |
Soy Formula | CYP4A21 | Increased Hepatic Expression | Ronis et al. (2011a) | |
SPI | CYP4A10 | Reduced Hepatic Expression | Simmen et al. (2010) | |
Soy Formula | CYP4A24 | No Effect | Ronis et al. (2011a) | |
SPI | Reduced Steatosis, Increased | PPARα Activation | Mezei et al. (2003; 2006) | |
Downstream Gene Expression | Badger et al. (2008), Ronis et al. (2009) | |||
SPI | Increased PPARα Expression | Ronis et al. (2009) | ||
Genistein, Daidzein | No Effect on PPARα-Dependent Genes | Ronis et al. (2009) | ||
In Vitro Studies | ||||
Genistein, Daidzein | PPARα Activation, Induction of Dependent Genes | Ligand Binding | Mezei et al. (2003; 2006) Shay and Banz (2005) | |
Genistein, Daidzein, Isoflavones | PPARα Activation, 2 Hybrid System | Ligand Binding | Ricketts et al. (2005) | |
Genistein | CYP4F2 | Induction in HepG2 cells | AMPK Activation | Hsu et al. (2011) |
CYP4A14 - mouse; CYP4A21, CYP4A24 - piglet; CYP4A10 - rat; CYP4F2